Cipla Tofacitinib Tabletd IP 5 mg Tofajak

About Cipla Tofacitinib Tabletd IP 5 mg Tofajak

Tofacitinib Tablets IP 5 mg (Brand: Tofajak) is a prescription medication manufactured by Cipla Ltd., widely used in the treatment of autoimmune and inflammatory disorders. It belongs to the class of Janus Kinase (JAK) inhibitors, which work by modulating the immune system and reducing inflammation.

Tofajak is commonly prescribed for patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis, especially in cases where conventional therapies have shown inadequate response.

• Rheumatoid Arthritis

• Psoriatic Arthritis

• Ulcerative Colitis

• Other autoimmune inflammatory conditions (as prescribed)

• Helps reduce joint pain, swelling, and stiffness

• Controls inflammation at the cellular level

• Improves mobility and quality of life

• Trusted Cipla quality and compliance

Dosage should be taken strictly as directed by a registered medical practitioner.

• Store in a cool, dry place

• Protect from light and moisture

• Keep out of reach of children